Geron Ownership | Who Owns Geron?
Geron Ownership Summary
Geron is owned by 77.20% institutional investors, 0.09% insiders, and 22.71% retail investors. Ra capital management is the largest institutional shareholder, holding 9.06% of GERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Geron shares.
GERN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Geron | 77.20% | 0.09% | 22.71% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 60.38M | 9.06% | $85.13M |
| Blackrock | 46.55M | 7.71% | $197.38M |
| Blackrock funding, inc. /de | 50.02M | 7.51% | $70.53M |
| Deep track capital, lp | 43.00M | 6.45% | $60.63M |
| Vanguard group | 33.54M | 5.07% | $118.73M |
| Janus henderson group | 27.08M | 4.09% | $95.77M |
| Vivo capital | 27.23M | 4.09% | $38.39M |
| State street | 22.55M | 3.74% | $95.61M |
| Vestal point capital, lp | 23.77M | 3.57% | $33.52M |
| Soleus capital management | 16.14M | 2.42% | $22.76M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 500.00K | 5.07% | $795.00K |
| Vivo capital | 27.23M | 3.93% | $38.39M |
| Ally bridge group (ny) | 3.25M | 3.81% | $4.58M |
| Exome asset management | 3.41M | 3.04% | $4.81M |
| Stempoint capital lp | 6.65M | 3.01% | $9.38M |
| Deep track capital, lp | 43.00M | 1.94% | $60.63M |
| Vestal point capital, lp | 23.77M | 1.76% | $33.52M |
| Soleus capital management | 16.14M | 1.51% | $22.76M |
| Ra capital management | 60.38M | 1.43% | $85.13M |
| Stonepine capital management | 1.00M | 1.38% | $1.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 16.14M | 1.51% | 13.74M |
| Eversept partners, lp | 7.32M | 0.95% | 7.32M |
| Stempoint capital lp | 6.65M | 3.01% | 5.69M |
| Blackrock | 46.55M | 0.00% | 5.14M |
| Deep track capital, lp | 43.00M | 1.94% | 4.82M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | - | - | -44.11M |
| Holocene advisors, lp | - | - | -22.20M |
| Adage capital partners gp | - | - | -21.80M |
| Tcg crossover management | - | - | -17.39M |
| Bioimpact capital | - | - | -10.48M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eversept partners, lp | 7.32M | 0.95% | 7.32M | $10.32M |
| Nan fung trinity (hk) | 1.37M | 0.23% | 1.37M | $1.94M |
| Alps advisors | 343.56K | 0.00% | 343.56K | $484.42K |
| Guggenheim capital | 214.83K | 0.01% | 214.83K | $760.49K |
| Gsa capital partners llp | 138.89K | 0.04% | 138.89K | $492.00K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -1.00 |
| Ifp advisors | -10.00 |
| Smartleaf asset management | -64.00 |
| Nelson, van denburg & campbell wealth management group | -96.00 |
| Geowealth management | -96.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 257 | -6.20% | 514,289,584 | 0.89% | 77 | 1.32% | 125 | -10.71% | 71 | 1.43% |
| Mar 31, 2025 | 14 | -95.19% | 143,280,723 | -70.72% | 21 | 0.39% | 10 | -93.51% | 2 | -96.97% |
| Dec 31, 2024 | 123 | -53.58% | 152,695,838 | -69.98% | 23 | 0.39% | 60 | -54.89% | 24 | -58.62% |
| Sep 30, 2024 | 264 | 7.32% | 508,658,981 | 9.50% | 76 | 1.52% | 132 | -4.35% | 58 | 13.73% |
| Jun 30, 2024 | 244 | 2.52% | 464,410,765 | 7.02% | 76 | 1.49% | 137 | 16.10% | 51 | -16.39% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 19.23M | 3.02% | -426.49K |
| Vanguard US Total Market Shares ETF | 17.83M | 2.80% | 17.67K |
| iShares Russell 2000 ETF | 14.15M | 2.22% | -268.90K |
| BioPharma Credit Ord | 14.12M | 2.22% | 14.12M |
| SPDR® S&P Biotech ETF | 10.04M | 1.58% | 247.94K |
| Vanguard Explorer Inv | 8.92M | 1.40% | 3.12M |
| Eventide Healthcare & Life Sciences I | 7.07M | 1.11% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 6.10M | 0.96% | -2.66M |
| Fidelity Small Cap Index | 6.01M | 0.94% | -5.72K |
| iShares Russell 2000 Growth ETF | 5.28M | 0.83% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 09, 2025 | LAWLIS V BRYAN | - | Buy | $15.67K |
| Feb 27, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Buy | $24.15K |
| Feb 27, 2025 | SCARLETT JOHN A | Chairman, President and CEO | Buy | $22.06K |
| Feb 27, 2025 | Ziegler James | EVP, Chief Commercial Officer | Buy | $160.00K |
| Jul 08, 2024 | GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Sell | $3.07M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 1 |
GERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools